gene-based

He heads a separate research unit that Pfizer opened last year to search for medications for certain distinctively gene-based rare diseases, such as muscular dystrophy and hereditary emphysema.

Push to spur more drugs for deadly rare diseases 2011

Wilson hoped that the fecund new gene-based ideas could be extended to provide the basis for understanding the evolution of social behavior, whether in social insects or social vertebrates, from murders of crows to flocks of sheep.

SuperCooperators Martin A. Nowak 2011

Quest Diagnostics agreed Friday to acquire Celera Corp. for about $344 million as the company seeks to expand in gene-based medical testing.

Quest Diagnostics to Acquire Celera Tess Stynes 2011

He heads a separate research unit that Pfizer opened last year to search for medications for certain distinctively gene-based rare diseases, such as muscular dystrophy and hereditary emphysema.

Push to spur more drugs for deadly rare diseases 2011

When companies hold exclusive licenses for human genes, competition to develop gene-based applications can be restricted, prices inflated and innovation slowed, some geneticists say.

Gene Ruling Could Have Broad Reach Shirley S. Wang 2010

The decision's near-term impact on companies that develop and market gene-based tests and treatments is likely to be limited, in part because most rely on patents that protect their drugs, not specific gene sequences.

Gene Ruling Could Have Broad Reach Shirley S. Wang 2010

The decision's near-term impact on companies that develop and market gene-based tests and treatments is likely to be limited, in part because most rely on patents that protect their drugs, not specific gene sequences.

Gene Ruling Could Have Broad Reach Shirley S. Wang 2010

The decision's near-term impact on companies that develop and market gene-based tests and treatments is likely to be limited, in part because most rely on patents that protect their drugs, not specific gene sequences.

Gene Ruling Could Have Broad Reach Shirley S. Wang 2010

When companies hold exclusive licenses for human genes, competition to develop gene-based applications can be restricted, prices inflated and innovation slowed, some geneticists say.

Gene Ruling Could Have Broad Reach Shirley S. Wang 2010

In a report likely to intensify the controversy over gene patents, Duke University researchers concluded that exclusive licensing of gene-based diagnostic tests may deprive many patients of the benefits of genetic discoveries and obstruct development of technologies that hold promise for transforming knowledge of human disease.

Gene-Patent Licenses Could Hurt Research, Study Says Amy Dockser Marcus 2010